Human Normal Immunoglobulin & Anti-D Immunoglobulin
Awarded by NHS ENGLAND · 2021-01-15T17:47:13Z · £450,000,000
Description
Human Normal Immunoglobulin and Anti-D Immunoglobulin: Period of framework agreement: 1 July 2021 to 31 December 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
- Buyer
- NHS ENGLAND
- Value
- £450,000,000
- Category (CPV)
- Immunoglobulins
- Award date
- 2021-01-15T17:47:13Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.